Literature DB >> 16768463

Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha).

Heather A Hostetler1, Ann B Kier, Friedhelm Schroeder.   

Abstract

Very-long-chain fatty acids (VLCFA) and branched-chain fatty acids (BCFA) are potent inducers of the peroxisome proliferator-activated receptor PPARalpha, a nuclear receptor that enhances transcription of peroxisomal enzymes mediating beta-oxidation of these potentially toxic fatty acids. However, it is not known whether the respective free fatty acids or their activated metabolites, i.e., CoA thioesters, (i) are the endogenous high-affinity PPARalpha ligands, (ii) alter PPARalpha conformation, and (iii) alter recruitment of coregulatory proteins to PPARalpha. As shown by quenching of PPARalpha intrinsic amino acid fluorescence, PPARalpha exhibited high affinity (3-29 nM Kds) for the CoA thioesters of the common (C20-C24) VLCFA. In contrast, with the exception of arachidonic acid (Kd = 20 nM), PPARalpha only weakly bound the VLCFA. PPARalpha also exhibited higher affinity for the CoA thioesters of BCFA (phytanoyl-CoA, pristanoyl-CoA; Kds near 11 nM) than for the respective free branched-chain fatty acids. As shown by circular dichroism, the high affinity VLCFA-CoA and BCFA-CoA strongly altered PPARalpha conformation. Likewise, the high affinity VLCFA-CoA and BCFA-CoA altered cofactor recruitment to PPARalpha as shown by coimmunoprecipitation from liver homogenates. In contrast, nearly all the respective free fatty acids elicited only weak conformational changes in PPARalpha and did not alter cofactor recruitment to PPARalpha. In summary, the CoA thioesters of very-long-chain and branched-chain fatty acids are much more potent PPARalpha ligands than the free acids, resulting in altered PPARalpha conformation and cofactor recruitment. Since these are hallmarks of ligand-activated nuclear receptors, this suggests that the CoA thioesters are the active forms of these PPARalpha ligands.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16768463      PMCID: PMC2593851          DOI: 10.1021/bi060198l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

Review 1.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently.

Authors:  T M Lewin; J H Kim; D A Granger; J E Vance; R A Coleman
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

3.  Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

Authors:  Friedhelm Schroeder; Huan Huang; Heather A Hostetler; Anca D Petrescu; Rachel Hertz; Jacob Bar-Tana; Ann B Kier
Journal:  Lipids       Date:  2005-06       Impact factor: 1.880

Review 4.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.

Authors:  J K Reddy; T Hashimoto
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

5.  Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

Authors:  H E Xu; M H Lambert; V G Montana; K D Plunket; L B Moore; J L Collins; J A Oplinger; S A Kliewer; R T Gampe; D D McKee; J T Moore; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.

Authors:  N Sreerama; R W Woody
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

7.  Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.

Authors:  S Fourcade; S Savary; S Albet; D Gauthé; C Gondcaille; T Pineau; J Bellenger; M Bentejac; A Holzinger; J Berger; M Bugaut
Journal:  Eur J Biochem       Date:  2001-06

Review 8.  Peroxisome proliferator-activated receptors: insight into multiple cellular functions.

Authors:  P Escher; W Wahli
Journal:  Mutat Res       Date:  2000-03-17       Impact factor: 2.433

9.  Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.

Authors:  P Cronet; J F Petersen; R Folmer; N Blomberg; K Sjöblom; U Karlsson; E L Lindstedt; K Bamberg
Journal:  Structure       Date:  2001-08       Impact factor: 5.006

Review 10.  PPARs: transcriptional effectors of fatty acids and their derivatives.

Authors:  A K Hihi; L Michalik; W Wahli
Journal:  Cell Mol Life Sci       Date:  2002-05       Impact factor: 9.261

View more
  38 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Fatty acid induced remodeling within the human liver fatty acid-binding protein.

Authors:  Ashwani Sharma; Amit Sharma
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

3.  Liver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity.

Authors:  Gregory G Martin; Barbara P Atshaves; Avery L McIntosh; John T Mackie; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

Review 4.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

5.  Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α.

Authors:  Heather A Hostetler; Madhumitha Balanarasimha; Huan Huang; Matthew S Kelzer; Alagammai Kaliappan; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2010-07-13       Impact factor: 5.922

6.  Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity.

Authors:  Sadeesh K Ramakrishnan; Lucia Russo; Simona S Ghanem; Payal R Patel; Ana Maria Oyarce; Garrett Heinrich; Sonia M Najjar
Journal:  J Biol Chem       Date:  2016-09-23       Impact factor: 5.157

7.  Phytol-induced hepatotoxicity in mice.

Authors:  John T Mackie; Barbara P Atshaves; H Ross Payne; Avery L McIntosh; Friedhelm Schroeder; Ann B Kier
Journal:  Toxicol Pathol       Date:  2009-02-02       Impact factor: 1.902

8.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.

Authors:  James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  PPAR Res       Date:  2010-03-16       Impact factor: 4.964

9.  L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.

Authors:  Heather A Hostetler; Avery L McIntosh; Barbara P Atshaves; Stephen M Storey; H Ross Payne; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2009-03-16       Impact factor: 5.922

10.  Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.

Authors:  Avery L McIntosh; Barbara P Atshaves; Heather A Hostetler; Huan Huang; Jason Davis; Olga I Lyuksyutova; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2009-03-12       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.